Los puntos clave no están disponibles para este artículo en este momento.
In routine clinical practice in Italy, patients with T2D treated with once-weekly semaglutide for 30 weeks achieved clinically significant improvements in HbA1c, body weight and other outcomes.
Napoli et al. (Wed,) studied this question.